Lung Squamous Cell Carcinoma — Trials

Lung Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07831863	A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy	not yet recruiting	Phase 3	600	Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY	1	Sep 21, 2026	clinicaltrials
NCT07806500	Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors	not yet recruiting	Phase 1	18	Beijing Anjianxi Bio-Medical Technology Co., Ltd.INDUSTRY	1	Sep 8, 2026